---
figid: PMC11011857__cells-13-00602-g003
figtitle: Genetic Signature of Human Pancreatic Cancer and Personalized Targeting
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC11011857
filename: cells-13-00602-g003.jpg
figlink: /pmc/articles/PMC11011857/figure/cells-13-00602-f003/
number: F3
caption: 'The main oncogenic pathways of KRAS activation are shown in the diagram:
  the MAPKinases [,] are on the left and the PI3K/AKT/mTOR [] are on the right. While
  the MAPKinases mediate proliferative signals, the PI3K pathway enhances survival,
  resistance to apoptosis and synthesis of essential molecules necessary for growth
  and proliferation. Oncogenic mutations in KRAS stabilizes its binding with GTP,
  leading to the constitutive activation of its downstream signaling.'
papertitle: Genetic Signature of Human Pancreatic Cancer and Personalized Targeting.
reftext: Stephan J. Reshkin, et al. Cells. 2024 Apr;13(7):602.
year: '2024'
doi: 10.3390/cells13070602
journal_title: Cells
journal_nlm_ta: Cells
publisher_name: MDPI
keywords: PDAC (pancreatic ductal adenocarcinoma) | driver mutations | KRAS | personalized
  treatment
automl_pathway: 0.953418
figid_alias: PMC11011857__F3
figtype: Figure
redirect_from: /figures/PMC11011857__F3
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC11011857__cells-13-00602-g003.html
  '@type': Dataset
  description: 'The main oncogenic pathways of KRAS activation are shown in the diagram:
    the MAPKinases [,] are on the left and the PI3K/AKT/mTOR [] are on the right.
    While the MAPKinases mediate proliferative signals, the PI3K pathway enhances
    survival, resistance to apoptosis and synthesis of essential molecules necessary
    for growth and proliferation. Oncogenic mutations in KRAS stabilizes its binding
    with GTP, leading to the constitutive activation of its downstream signaling.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - EGF
  - EGFR
  - KRAS
  - NRAS
  - MTG1
  - ITGA1
  - ITGA10
  - ITGA11
  - ITGA2
  - ITGA2B
  - ITGA3
  - ITGA4
  - ITGA5
  - ITGA6
  - ITGA7
  - ITGA8
  - ITGA9
  - ITGAD
  - ITGAE
  - ITGAL
  - ITGAM
  - ITGAV
  - ITGAX
  - ITGB1
  - ITGB2
  - ITGB3
  - ITGB4
  - ITGB5
  - ITGB6
  - ITGB7
  - ITGB8
  - ITGBL1
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - NFKB1
  - RELA
  - RELB
  - REL
  - NFKB2
  - AKT1
  - AKT2
  - AKT3
  - PRRT2
  - PRKCA
  - PRKCB
  - PRKCD
  - PRKCE
  - PRKCG
  - PRKCH
  - PRKCI
  - PRKCQ
  - PRKCZ
  - PRKD3
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - MTOR
  - MAPK3
  - MAPK1
  - EPHB2
  - EGF
  - GTP
  - PHOSPHO
  - MEK
  - cancer
---
